Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-6301

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-6301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 01)

Chemical structure of venlafaxine hydrochloride, showing its molecular bonds and functional groups including a methoxy-substituted benzene ring and a cyclohexane ring.*

FDA Label Image

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 02)

A scatter plot graph showing fold changes with 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its metabolite ODV relative to reference values. The data is categorized by special populations, including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60 years, and gender differences (female/male). The x-axis represents the change relative to the reference value from 0 to 3.5.*

FDA Label Image

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 03)

Pharmacokinetic interaction chart showing fold changes and 90% confidence intervals in venlafaxine levels and its O-desmethylvenlafaxine (ODV) metabolite when co-administered with various drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EMs and PMs), indinavir, metoprolol, imipramine, and lithium. The chart displays changes in Cmax and AUC values relative to the reference, illustrating the degree of interaction affecting venlafaxine pharmacokinetics.*

FDA Label Image

Image (8c02c121 Fe14 45f5 B2bc B09fd377531f 04)

A forest plot chart displaying the fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various analytes when interacting with specified drugs, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, toltubamide, and lithium. The x-axis represents change relative to a reference value.*

FDA Label Image

Label Image (Lbl500906301)

Label for venlafaxine hydrochloride extended-release 37.5 mg capsules from A-S Medication Solutions. The white label includes dosage form and strength information, storage instructions (store at 68 to 77 degrees F), quantity (33 unit dose capsules), and NDC 50090-6301. It also features a barcode and lot number space, indicating the product is for oral use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.